Guideline on the treatment of blood cholesterol: Difference between revisions
Jump to navigation
Jump to search
m (Sara Mehrsefat moved page ACC AHA guideline on the treatment of blood cholesterol to Guideline on the treatment of blood cholesterol) |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==[[ACC AHA guideline on the treatment of blood cholesterol|ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce ASCV Risk in Adults]]== | ==[[2013 ACC AHA guideline on the treatment of blood cholesterol|ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce ASCV Risk in Adults]]== | ||
[[File:ACCAHA cholesterol treatment algorithm.jpg|900px]] | [[File:ACCAHA cholesterol treatment algorithm.jpg|900px]] | ||
===[[ACC AHA guideline on the treatment of blood cholesterol statin treatment|Statin Treatment]]=== | ===[[ACC AHA guideline on the treatment of blood cholesterol statin treatment|Statin Treatment]]=== | ||
Revision as of 18:11, 28 October 2016
Template:Hypercholesterolemia Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce ASCV Risk in Adults
Statin Treatment
Intensity of Statin Therapy | LDL and Non-HDL Treatment Goals | Primary Prevention | Secondary Prevention | Heart Failure and Hemodialysis
Safety
Managing Statin Therapy
Monitoring Statin Therapy | Optimizing statin therapy | Insufficient Response